SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950127-00-000584
Filing Date
2000-11-22
Accepted
2000-11-22 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G 0001.txt SC 13G 13912
  Complete submission text file 0000950127-00-000584.txt   15891
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Subject) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47221 | Film No.: 775704
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN I8
Business Address TAUNUSANLAGE 12 D-60325 FRANKFURT AM MAIN GE I8
DEUTSCHE BANK AG\ (Filed by) CIK: 0000948046 (see all company filings)

State of Incorp.: I8